PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-01

Date Title Company
01-May-2026 Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA Orchard Therapeutics
01-May-2026 UCB announces acquisition of IMIDomics’ Patient Insight Business, strengthening capabilities in immune-mediated inflammatory diseases (IMIDs) UCB